DE68903937D1 - Waessrige elcatonin-loesung enthaltende arzneizubereitung. - Google Patents

Waessrige elcatonin-loesung enthaltende arzneizubereitung.

Info

Publication number
DE68903937D1
DE68903937D1 DE8989120254T DE68903937T DE68903937D1 DE 68903937 D1 DE68903937 D1 DE 68903937D1 DE 8989120254 T DE8989120254 T DE 8989120254T DE 68903937 T DE68903937 T DE 68903937T DE 68903937 D1 DE68903937 D1 DE 68903937D1
Authority
DE
Germany
Prior art keywords
preparation containing
active ingredient
containing aqueous
elcatonin
medical preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8989120254T
Other languages
English (en)
Other versions
DE68903937T2 (de
Inventor
Hitoshi Yamada
Ken Endo
Kikuo Kotani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Publication of DE68903937D1 publication Critical patent/DE68903937D1/de
Application granted granted Critical
Publication of DE68903937T2 publication Critical patent/DE68903937T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8989120254T 1988-12-23 1989-11-02 Waessrige elcatonin-loesung enthaltende arzneizubereitung. Expired - Lifetime DE68903937T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63324999A JPH02174726A (ja) 1988-12-23 1988-12-23 エルカトニン水溶液組成物の安定化法

Publications (2)

Publication Number Publication Date
DE68903937D1 true DE68903937D1 (de) 1993-01-28
DE68903937T2 DE68903937T2 (de) 1993-04-22

Family

ID=18172004

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989120254T Expired - Lifetime DE68903937T2 (de) 1988-12-23 1989-11-02 Waessrige elcatonin-loesung enthaltende arzneizubereitung.

Country Status (10)

Country Link
US (1) US4977139A (de)
EP (1) EP0375885B1 (de)
JP (1) JPH02174726A (de)
KR (1) KR950003493B1 (de)
AT (1) ATE83380T1 (de)
AU (1) AU629142B2 (de)
CA (1) CA2001671C (de)
DE (1) DE68903937T2 (de)
ES (1) ES2052861T3 (de)
GR (1) GR3007338T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3179538B2 (ja) * 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト 安定なヒトカルシトニンの水性溶液
US5571788A (en) * 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
US5721207A (en) * 1995-04-18 1998-02-24 Innapharma, Inc. Method for treatment of pain
EP1391209A4 (de) * 2001-05-30 2009-12-16 Chugai Pharmaceutical Co Ltd Proteinzubereitung
JP2002037737A (ja) * 2001-08-02 2002-02-06 Nippon Kayaku Co Ltd ブレオマイシン類の安定な水溶液

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51128993A (en) * 1975-05-01 1976-11-10 Tanpakushitsu Kenkyu Shiyoureikai Process for preparing new polypeptides
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤

Also Published As

Publication number Publication date
JPH02174726A (ja) 1990-07-06
ATE83380T1 (de) 1993-01-15
AU4397589A (en) 1990-06-28
JPH0524137B2 (de) 1993-04-06
CA2001671C (en) 1995-10-17
EP0375885A1 (de) 1990-07-04
KR900009089A (ko) 1990-07-02
CA2001671A1 (en) 1990-06-23
AU629142B2 (en) 1992-09-24
US4977139A (en) 1990-12-11
DE68903937T2 (de) 1993-04-22
GR3007338T3 (de) 1993-07-30
KR950003493B1 (ko) 1995-04-13
EP0375885B1 (de) 1992-12-16
ES2052861T3 (es) 1994-07-16

Similar Documents

Publication Publication Date Title
EP0183527B1 (de) Absorbierbares Calcitoninarzneimittel
NZ240901A (en) Stabilised human calcitonin solution
DE68903937D1 (de) Waessrige elcatonin-loesung enthaltende arzneizubereitung.
DE3570437D1 (en) 1-hydroxy-1,1-diphosphonic-acid derivatives, process for their preparation and pharmaceutical preparations, especially for the treatment of bone tumours
WO2003086324A3 (en) Preparation and use of a stable formulation of allosteric effector compounds
EP0353821A3 (de) Antipsychotische 3-Piperazinylbenzazolderivate
EP0208417A3 (de) Verwendung von 1-(8alpha-Ergolinyl)-3,3-diethylureaderivaten zur Behandlung von Endometritis
RU95109157A (ru) Противогипергликемически эффективная фармацевтическая композиция
EP0209843A3 (de) Benzylpiperazin-Verbindung, deren Herstellung, pharmazeutische Zusammensetzung und Verwendung
SE8404560L (sv) Saneringskomposition
DK458484D0 (da) Hydroethylazolderivater, eller syreadditionssalte eller metalsaltkomplekser deraf, deres fremstilling og anvendelse som fungicider
HUT42757A (en) Fungicidal compositions comprising heterocyclic amide derivatives as active substance and process for preparing the active substance
DK163663C (da) Hydroxyethyl-azol-derivater til behandling af mykoser, disse forbindelsers anvendelse til fremstilling af laegemidler samt farmaceutisk praeparat indeholdende mindst en af forbindelserne
EP0323189A3 (de) Optisch aktive Benzochinolizin-Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende bakterizide Mittel
PT79821A (fr) Procede de preparation d'aminoethylimidazole comme de la composition pharmaceutique en contenant utilise comme medicament cytoprotecteur
JPH078807B2 (ja) エルカトニン組成物
JPH0366290B2 (de)
JPH0429938A (ja) カルシトニン類水溶液組成物の安定化法
RU2006123317A (ru) Состав раствора эритропоэтина
ITRM910590A1 (it) Procedimento ellettrochimico per la preparazione dell'acido 4, 4'- dinitrostilben- 2, 2, ' -disolfonico e dei relativi sali

Legal Events

Date Code Title Description
8364 No opposition during term of opposition